Although Paxlovid sounds promising, there are likely to not be enough. Pfizer stated that it will produce 180,000 course courses in the next month, and then ramp up to 50,000,000 courses by 2022. Pfizer announced this week that generic drug producers will be allowed to manufacture the Pill and deliver it to 95 low- and middle-income nations. As long as Covid remains an international health emergency, Pfizer is willing to waive royalty payments for countries with low incomes. This is the latest news. Stay tuned for new updates.